We are live on ! Find out more
ATRS

Antares Pharma, Inc.
ATRS

Delisted

ATRS was delisted on the 23rd of May, 2022.

Back to rankings

132 hedge funds and large institutions have $209M invested in Antares Pharma, Inc. in 2019 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 38 increasing their positions, 34 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

92% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 13

15% more capital invested

Capital invested by funds: $181M → $209M (+$27.8M)

12% more repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 34

10% more funds holding

Funds holding: 120 → 132 (+12)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

22% less call options, than puts

Call options by funds: $1.77M | Put options by funds: $2.26M

Holders
132
Holders Change
+12
Holders Change %
+10%
% of All Funds
2.86%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
25
Increased
38
Reduced
34
Closed
13
Calls
$1.77M
Puts
$2.26M
Net Calls
-$490K
Net Calls Change
+$367K

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$4.26M
2
CAM
Cortina Asset Management
Wisconsin
+$3.35M
3
Deutsche Bank
Deutsche Bank
Germany
+$2.72M
4
PI
Putnam Investments
Massachusetts
+$1.84M
5
Renaissance Technologies
Renaissance Technologies
New York
+$1.34M

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$4.01M
2
BC
Broadfin Capital
New York
-$2.59M
3
Russell Investments Group
Russell Investments Group
United Kingdom
-$1.8M
4
State Street
State Street
Massachusetts
-$1.78M
5
BlackRock
BlackRock
New York
-$1.05M
Name Holding Trade Value Shares
Change 		Change in
Stake
Invesco
26
Invesco
Georgia
$1.32M +$51.7K +15,955 +4%
Russell Investments Group
27
Russell Investments Group
United Kingdom
$1.32M -$1.8M -554,218 -56%
Renaissance Technologies
28
Renaissance Technologies
New York
$1.25M +$1.34M +412,828 New
Two Sigma Advisers
29
Two Sigma Advisers
New York
$1.19M +$223K +68,900 +21%
TA
30
Teachers Advisors
New York
$1.15M +$300K +92,437 +32%
Goldman Sachs
31
Goldman Sachs
New York
$1.02M +$659K +203,492 +152%
TCIM
32
TIAA CREF Investment Management
New York
$919K +$68.8K +21,242 +8%
AC
33
Avenir Corporation
Virginia
$874K -$4.86K -1,500 -0.5%
BAS
34
Brown Advisory Securities
Maryland
$833K – – –
Millennium Management
35
Millennium Management
New York
$816K -$4.01M -1,238,493 -82%
QI
36
QS Investors
New York
$803K +$859K +265,000 New
Swiss National Bank
37
Swiss National Bank
Switzerland
$783K +$25.6K +7,900 +3%
Wells Fargo
38
Wells Fargo
California
$777K +$64.5K +19,889 +8%
HVC
39
Healthcare Value Capital
New Jersey
$758K – – –
AAMU
40
Amundi Asset Management US
Massachusetts
$730K +$781K +240,962 New
JG
41
Jefferies Group
New York
$682K +$729K +225,000 New
California State Teachers Retirement System (CalSTRS)
42
California State Teachers Retirement System (CalSTRS)
California
$670K -$16.7K -5,140 -2%
Baird Financial Group
43
Baird Financial Group
Wisconsin
$581K – – –
RhumbLine Advisers
44
RhumbLine Advisers
Massachusetts
$557K -$10.2K -3,158 -2%
Citadel Advisors
45
Citadel Advisors
Florida
$495K +$214K +66,142 +68%
BFM
46
Boothbay Fund Management
New York
$484K +$518K +159,782 New
PNC Financial Services Group
47
PNC Financial Services Group
Pennsylvania
$481K -$206K -63,445 -29%
AllianceBernstein
48
AllianceBernstein
Tennessee
$429K +$17.2K +5,300 +4%
CIBC Private Wealth Group
49
CIBC Private Wealth Group
Georgia
$379K – – –
PPA
50
Parametric Portfolio Associates
Washington
$350K -$2.15K -665 -0.6%
1
2
3 4 5

ATRS Hedge Fund Activity: Q1 2019 in Review

132 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Antares Pharma, Inc. (ATRS) for Q1 2019, worth a combined $209M — up 15% from $181M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new ATRS positions and 13 closed out — a net gain of 12 holders — while 38 added to existing stakes and 34 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $4.26M. The largest seller was Millennium Management, cutting an estimated $4.01M.

  • 132 institutional investors held Antares Pharma, Inc. (ATRS) as of Q1 2019, up from 120 in Q4 2018.
  • Funds reported $209M of Antares Pharma, Inc. stock for Q1 2019, up 15% quarter-over-quarter.
  • 25 funds opened new Antares Pharma, Inc. positions in Q1 2019 and 13 closed out, a net change of +12 holders.
  • The largest Antares Pharma, Inc. buyer in Q1 2019 was Morgan Stanley, an estimated $4.26M added.
  • The largest Antares Pharma, Inc. seller in Q1 2019 was Millennium Management, an estimated $4.01M sold.

Based on aggregated 13F filings for Q1 2019.